378 related articles for article (PubMed ID: 37725503)
1. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
2. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
3. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
4. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: anatomic site and histology differences.
Wu XC; Andrews P; Chen VW; Groves FD
Cancer Epidemiol; 2009 Nov; 33(5):337-46. PubMed ID: 19853554
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer: 20-Year Comparative Mortality and Survival Analysis by Age, Sex, Race/Ethnicity, Stage, Grade, Disease Duration, Selected ICD-O-3 Oncophenotypes, and Cohort Entry Time-Period.
Milano AF
J Insur Med; 2023 Jul; 50(2):80-122. PubMed ID: 38358929
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin's lymphoma.
Greiner TC; Medeiros LJ; Jaffe ES
Cancer; 1995 Jan; 75(1 Suppl):370-80. PubMed ID: 8001008
[TBL] [Abstract][Full Text] [Related]
7. Extranodal lymphoma: a comparative study.
AlShemmari SH; Ameen RM; Sajnani KP
Hematology; 2008 Jun; 13(3):163-9. PubMed ID: 18702874
[TBL] [Abstract][Full Text] [Related]
8. Non-Hodgkin's lymphoma: an analysis of the Metropolitan Detroit SEER database.
Varterasian ML; Graff JJ; Severson RK; Weiss L; al-Katib AM; Kalemkerian GP
Cancer Invest; 2000; 18(4):303-8. PubMed ID: 10808365
[TBL] [Abstract][Full Text] [Related]
9. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995.
Groves FD; Linet MS; Travis LB; Devesa SS
J Natl Cancer Inst; 2000 Aug; 92(15):1240-51. PubMed ID: 10922409
[TBL] [Abstract][Full Text] [Related]
10. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group.
Coté TR; Biggar RJ; Rosenberg PS; Devesa SS; Percy C; Yellin FJ; Lemp G; Hardy C; Geodert JJ; Blattner WA
Int J Cancer; 1997 Nov; 73(5):645-50. PubMed ID: 9398040
[TBL] [Abstract][Full Text] [Related]
11. Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Years 1993-2013.
Milano AF
J Insur Med; 2018 Jan; 47(3):143-158. PubMed ID: 30192723
[TBL] [Abstract][Full Text] [Related]
12. A retrospective comparison of early stage primary extranodal with nodal non-Hodgkin lymphoma patients: A single center experience.
Yazilitas D; Ozdemir N; Hocazade C; Bozkaya Y; Yazici O; Sendur MA; Zengin N
J BUON; 2015; 20(6):1526-33. PubMed ID: 26854450
[TBL] [Abstract][Full Text] [Related]
13. Extranodal non-Hodgkin's lymphomas--a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin's lymphomas.
Lal A; Bhurgri Y; Vaziri I; Rizvi NB; Sadaf A; Sartajuddin S; Islam M; Kumar P; Adil S; Kakepoto GN; Masood N; Khurshed M; Alidina A
Asian Pac J Cancer Prev; 2008; 9(3):453-8. PubMed ID: 19004134
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and Determinants of Survival for Primary Intestinal Non-Hodgkin Lymphoma: A Population-Based Study.
Singh V; Gor D; Gupta V; Jacob A; Du D; Eltoukhy H; Meghal T
World J Oncol; 2022 Aug; 13(4):159-171. PubMed ID: 36128593
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of Nasopharyngeal Lymphoma in the United States: A Population-Based Analysis of 1119 Cases.
Han AY; Kuan EC; Alonso JE; Badran KW; St John MA
Otolaryngol Head Neck Surg; 2017 May; 156(5):870-876. PubMed ID: 28322119
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand.
Mitarnun W; Suwiwat S; Pradutkanchana J
Asian Pac J Cancer Prev; 2006; 7(1):91-4. PubMed ID: 16629523
[TBL] [Abstract][Full Text] [Related]
17. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
18. The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan.
Chen WL; Tsai WC; Chao TY; Sheu LF; Chou JM; Kao WY; Chen YC; Ho CL
Ann Hematol; 2010 Jun; 89(6):553-62. PubMed ID: 20012434
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden.
Samuelsson BO; Ridell B; Röckert L; Gustafsson G; Márky I
J Pediatr Hematol Oncol; 1999; 21(2):103-10. PubMed ID: 10206455
[TBL] [Abstract][Full Text] [Related]
20. Primary extranodal and nodal non-Hodgkin's lymphoma. A survey of a population-based registry.
Otter R; Gerrits WB; vd Sandt MM; Hermans J; Willemze R
Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1203-10. PubMed ID: 2767109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
